China Tobacco Hong Kong (06055.HK) 2024 Mid-Year Report: Total Revenue Up 12% to 8.7B HKD, NGPs Soar by 28%

Business by 2FIRSTS.ai
Aug.28.2024
China Tobacco Hong Kong (06055.HK) 2024 Mid-Year Report: Total Revenue Up 12% to 8.7B HKD, NGPs Soar by 28%
China Tobacco Hong Kong (06055.HK) revealed its mid-term financial report for 2024 on August 27. Company's total revenue rose 12%.

On August 27th, China Tobacco Hong Kong (06055.HK) released its interim performance report for 2024. During the period, the company's revenue reached 8.704 billion Hong Kong dollars, a 12% increase compared to the previous year; the company's attributable profit to equity holders reached 643 million Hong Kong dollars, a 41% increase year-on-year; and gross profit reached 964 million Hong Kong dollars, a 29% increase year-on-year.

China Tobacco Hong Kong (06055.HK) 2024 Mid-Year Report: Total Revenue Up 12% to 8.7B HKD, NGPs Soar by 28%
Image source: China Tobacco Hong Kong

 

  • The export business of new tobacco products has seen an increase in operating income, reaching 43.5 million Hong Kong dollars, a 28% year-on-year growth, with gross profit increasing by 57%. 
  • Cigarette export business has grown rapidly, with operating income reaching 547.3 million Hong Kong dollars, a 128% year-on-year growth, and gross profit increasing by 223%. 
  • The import and export of tobacco leaf products have seen stable growth, with import business income increasing by 5% year-on-year, and export business operating income increasing by 23% year-on-year. 
  • Operating income from business operations in Brazil has increased by 43% year-on-year, with gross profit decreasing by 8%.

 

The report reveals:

 

The company's growth in the new tobacco product sector is mainly attributed to tapping into key market channels, increasing customer marketing efforts, resulting in increased demand for orders in key markets; as well as continuously expanding their product portfolio, optimizing product pricing strategies, and increasing the proportion of self-operated business.

 

The company stated that the significant growth in cigarette export business was due to the continuous optimization of product portfolio, increased investment in new products, expansion of self-operated business, leading to a substantial increase in revenue and gross profit from cigarette export business. Additionally, foot traffic in duty-free markets has been steadily recovering, leading to improved product turnover compared to the same period last year.

 

Due to seasonal fluctuations in tobacco leaf production and an increase in the selling price of tobacco products, Chinese tobacco company CNTC's tobacco import business in Hong Kong saw a slight growth. The growth in tobacco export business is beneficial for increasing demand in the international market and optimizing pricing strategies.

 

Despite a significant increase in operating income in Brazil, gross profit has actually decreased compared to the same period last year. The company stated that this is due to a significant increase in the proportion of finished cigarette sales with high selling prices but low gross margins, while the proportion of product sales with high gross margins but lower selling prices has decreased.

 

In addition, China Tobacco Hong Kong stated that in the second half of this year, they will continue to enhance the international visibility of new tobacco products, deepen cooperation between production and sales, and comprehensively promote innovation in new tobacco technology and product upgrades.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Thai Officials Meet WHO Chief to Discuss E-Cigarette Risks and Control Measures
Thai Officials Meet WHO Chief to Discuss E-Cigarette Risks and Control Measures
Thai officials met the WHO chief to discuss youth vaping risks. The WHO warned of flavored products targeting teens, while Thailand pledged stricter controls and school awareness campaigns.
Jul.17 by 2FIRSTS.ai
2Firsts Interview | Malawi’s Economic Engine: TAMA Farmers Trust CEO Reflects on the Current Marketing Season and Malawi’s Heavy Tobacco Dependence
2Firsts Interview | Malawi’s Economic Engine: TAMA Farmers Trust CEO Reflects on the Current Marketing Season and Malawi’s Heavy Tobacco Dependence
Malawi relies heavily on tobacco, which generates over 50% of foreign exchange and 12% of GDP. In 2025, output is expected to reach 175 million kg, but lower prices and rising costs hurt profits. TAMA CEO Nixon Lita discusses climate effects, market pressures, diversification, and challenges from next-generation nicotine products.
Jul.30
Haypp Expands U.S. Team, Appoints Senior Legal and Regulatory Executive
Haypp Expands U.S. Team, Appoints Senior Legal and Regulatory Executive
Swedish online retailer Haypp Group announces two key appointments: Issa Abuaita as U.S. Head of Legal, and Laura Leigh Oyler as U.S. Vice President of Regulatory Affairs.
Jul.08
TASS: Russian Government Halts E-Cigarette Ban Amid $2 Billion Tax Revenue Forecast
TASS: Russian Government Halts E-Cigarette Ban Amid $2 Billion Tax Revenue Forecast
Russia mandates honest labeling for e-cigarettes, doubling legal sales points; failure to comply can result in fines and imprisonment.
Aug.07 by 2FIRSTS.ai
Product | ELFBAR Launches JOINOne Series Featuring Magnetic Design and Adjustable Cooling
Product | ELFBAR Launches JOINOne Series Featuring Magnetic Design and Adjustable Cooling
ELFBAR has launched the JOINOne series, featuring two pod types—“Dock-to-Vape” and “Standalone Use”—with three-level cooling adjustment. The Dynamic and Lumeo devices offer three power modes. The series debuted at the 2025 Dubai Vape Expo and is now available on ELFBAR’s website.
Jul.24 by 2FIRSTS.ai
Exclusive Interview: How Dholakia Tobacco Built the Rush Brand and Entered the Global Nicotine Pouch Market
Exclusive Interview: How Dholakia Tobacco Built the Rush Brand and Entered the Global Nicotine Pouch Market
Dholakia Tobacco, a 150-year-old Indian tobacco company, is expanding globally with its nicotine pouch brand Rush. At the 2025 World Vape Show, CEO Nihar Dholakia and marketing head Rahoul Naik shared how Rush differentiates through transparent ingredients, lifestyle branding, and adaptive market strategies. Despite regulatory hurdles, the company maintains pharmaceutical-grade standards and is targeting growth in both established and emerging markets.
Jul.11